Skip to Content

B 417 (Mephobarbital 50 mg)

Pill with imprint B 417 is White, Round and has been identified as Mephobarbital 50 mg. It is supplied by Breckenridge Pharmaceutical Inc.

Mephobarbital is used in the treatment of sedation; epilepsy; seizure prevention and belongs to the drug classes barbiturate anticonvulsants, barbiturates. There is positive evidence of human fetal risk during pregnancy. Mephobarbital 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for B 417

Mephobarbital 50 mg B 417

Mephobarbital

Imprint
B 417
Strength
50 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Barbiturate anticonvulsants, Barbiturates
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Breckenridge Pharmaceutical Inc
National Drug Code (NDC)
51991-0417

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.